Marrakesh, Morocco • 29-31 October 2018
Following the first OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals (13-15 March 2013), recommendations of this important meeting led directly to continued capacity building in Member Countries through the OIE PVS pathway, strengthened collaboration with WHO and FAO through the tripartite alliance, and the creation of the first global database on the use of antimicrobial agents in animals.
Since this time, OIE monitoring activities have demonstrated impressive progress in its Member Countries towards combatting AMR in animals. In 2012, an OIE questionnaire showed that 27% of the 152 responding Member Countries had an official system in place for collecting quantitative data on antimicrobial agents used in animals. By the second phase of the OIE data collection on antimicrobial agents intended for use in animals, concluded in May 2016, 73% (107 out of 146 countries that replied) were able to provide quantitative data on antimicrobial agents intended for use in animals.
The results of Technical Item 1 of the 85th OIE General Session in 2017, ‘Global action to alleviate the threat of antimicrobial resistance: progress and opportunities for future activities under the ‘One Health’ initiative’ also highlighted areas of development in Member Countries. The percentage of Member Countries declaring no significant awareness-raising activities on AMR fell from 46% (before 2015) to 22% (after 2015). The proportion of Member Countries reporting no data collection on antimicrobial use in animals fell from 31% to 19% after 2015. In the same period, the proportion of Member Countries without a regular national AMR surveillance system or plan fell from 44% to 25%. Only 7% of reporting countries declared not having put in place any policy or legislation on the quality, efficacy and safety of medicinal products, and an increase was shown in use of OIE international standards and guidelines on antimicrobials across all OIE Regions.
These remarkable improvements demonstrate the significant impact a harmonised intergovernmental approach can achieve in tackling this global issue, while also highlighting areas where future growth is needed. Current work on antimicrobial resistance focuses primarily on antibiotics, while data shows that resistance to antiparasitics is of growing concern to animal health, welfare and productivity. Country reporting in monitoring and evaluation by the OIE and its Tripartite partners has also underscored the problem of substandard and falsified veterinary antimicrobials, which escape government regulation and surveillance aimed at reducing development of antimicrobial resistance, and with unknown contents, pose a risk to animal and human health.
To ensure a successful, harmonised and sustained response to antimicrobial resistance, international standards must be implemented at all levels, and in all areas regarding animal health and production. As Member Countries work to implement OIE standards nationally, engagement is essential from all stakeholders, such as the veterinary pharmaceutical industry, wholesale and retail distributors of veterinary antimicrobials, animal feed manufacturers, and veterinarians and food animal producers in the field. Achieving agreement and collaboration between these diverse and relevant stakeholders is the next step in capacity building on a national level.
To achieve measurable results at the global, regional and at country levels, the OIE and Member Countries should ensure strong engagement and communication between, and training of, these different sectors of the animal health industry. Within the animal health sector at a national level, a strong Veterinary Authority must ensure a comprehensive understanding and effective collaboration across the Veterinary Service, ensuring veterinarians, farmers, feed and pharmaceutical industries, are committed and engaged in the National Action Plan, each understanding their role, and are supported in developing the required competencies to achieve the shared goal of reducing development and spread of antimicrobial resistance. The Veterinary Service must build and sustain effective One Health partnerships at a national level.
Additionally, on an intergovernmental level, enhanced integration of the surveillance and monitoring activities of the three organisations of the Tripartite would also support a better understanding of how antimicrobials are consumed, and how resistance circulates within and between humans, animals and plants, and through food, water and the environment. Such understanding is necessary to inform areas for beneficial intervention strategies in the future, and measurement of their impacts.
Aim of the conference
The Second OIE Global Conference comes at a critical juncture in the fight against antimicrobial resistance. Member Countries have demonstrated an impressive commitment to development of national capacity in this effort in line with international standards. To build upon and further inform this momentum, the Second OIE Global Conference will bring together OIE Delegates and OIE National Focal Points for Veterinary Products, as well as experts, professionals, policy makers, international organisations and donors, with the aims to increase understanding of the current global situation on antimicrobial resistance in animals, and to develop recommendations for future sustained control of AMR while ensuring animal health, animal welfare, veterinary public health, and food security. Particularly, it will provide a forum to examine how to best support Member Countries in continued fulfilment of the objectives of the OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials, and the Global Action Plan on Antimicrobial Resistance.
The conference will in particular:
- Inform on initiatives taken by the Tripartite and other international organisations involved in One Health projects to control AMR in humans, animals, plants, and the environment at national, regional and international levels;
- present an overview of the progress achieved since the first OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals in 2013 on antimicrobial use in animals including the OIE global database on antimicrobial agents intended for use in animals;
- Promote implementation by all relevant stakeholders in OIE Member Countries of the OIE’s international standards and guidelines on the use of antimicrobial agents and antimicrobial resistance in animals, including the updated OIE List of Antimicrobial Agents of Veterinary Importance;
- Support the ongoing development of comprehensive surveillance and monitoring systems for antimicrobial use and resistance appropriate to different national and regional contexts;
- Encourage responsible and prudent use of veterinary antimicrobials in the field, including development of species-specific clinical guidelines, and engagement strategies for veterinarians and livestock producers;
- Promote access to high quality veterinary products worldwide and strategies to reduce dissemination of falsified and substandard products;
- Consider communication tools and interventions to generate key behavioural changes towards reducing use of antimicrobials in the field;
- Inform on the research and possible implementation of alternatives to antimicrobial agents;
- Discuss the development of guidance on the responsible and prudent use of antiparasitics;
- Encourage international solidarity in supporting the OIE and its Member Countries to effectively implement the OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials.
Dr Matthew Stone (World Organisation for Animal Health, OIE – Chair)
Dr Alain Dehove (OIE)
Dr Abderrahman El Abrak (Delegate of Morocco to the OIE – Office National de Sécurité Sanitaire des Produits Alimentaires – ONSSA)
Dr Elisabeth Erlacher-Vindel (OIE)
Dr Mara Gonzalez-Ortiz (OIE)
Dr Eric Thévenard (European Commission)
Dr Herbert Schneider (Scientific Committee Coordinator – Agrivet International Consultants, Namibia)
Dr Carolee Carson (Public Health Agency of Canada)
Dr Gérard Moulin (Agency for Food, Environmental and Occupational Health & Safety – ANMV/ANSES, France)
Dr Donald Prater (U.S. Food and Drug Administration)
Dr Masumi Sato (National Institute of Animal Health, Japan)
Dr Chris Teale (Animal and Plant Health Agency, UK)
Dr Jordi Torren Edo (European Medicines Agency – EMA)
Prof. Jacques Acar (Senior Expert – OIE)
Dr Elisabeth Erlacher-Vindel (OIE)
Dr Delfy Gochez (OIE)
Dr Awa Aidara-Kane (World Health Organisation – WHO)
Dr April Johnson (Food and Agriculture Organisation of the United Nations – FAO)
Dr Olivier Espeisse (HealthforAnimals)
Dr Mara Gonzalez-Ortiz (Organising Committee Coordinator – OIE)
Dr Khadija Id Sidi Yahia (ONSSA)
Dr Rachid Bouguedour (OIE SRR Tunis)
Ms Nelly Dubarry (OIE)
Dr Kimberly Calloway (OIE)
Dr François Diaz (OIE)
CALL FOR POSTERS
The call for posters is now closed.
The Posters Abstracts are available in the Book of Abstracts (please see below).
SESSION 1: SETTING THE SCENE
_ The Tripartite antimicrobial resistance work programme under the Global Action Plan, Matthew Stone, Deputy Director General, World Organisation for Animal Health, OIE
_ The United Nations Interagency Coordination Group on Antimicrobial Resistance, Sally Davies, Co-convener, United Nations Interagency Coordination Group on AMR
_ The economic case for investment in antimicrobial resistance, Juergen Voegele, Senior Director, Agriculture Global Practice, World Bank / Not available
SESSION 2: POLITICAL PANEL: ANIMAL HEALTH SECTOR PARTICIPATION IN ANTIMICROBIAL RESISTANCE NATIONAL ACTION PLANS
_ Minister’s round table
SESSION 3: BEHAVIOUR CHANGE AND COMMUNICATIONS STRATEGIES TOWARDS REDUCING ANTIMICROBIAL USE IN ANIMALS
_ New insights: applying behavioural science to the use of antimicrobial agents in livestock worldwide, Elizabeth Long, DTA Innovations
_ Global communication on antimicrobial resistance in animal health: OIE and Tripartite efforts, Catherine Bertrand-Ferrandis/Taylor Gabourie, World Organisation for Animal Health, OIE
_ Development of a communication strategy for animal health, Joseph Othieno, Kenya Tsetse and Trypanosomiasis Eradication Council
_ iAMResponsible: imparting a sense of accountability, ownership and responsibility among stakeholders in the fight against antimicrobial resistance (Part 1 / Part 2 /Part 3), Samuel Castro, Department of Agriculture of the Philippines
_ Identification of behaviour change drivers in key stakeholders, Christianne Bruschke, OIE Delegate, Nature and Food Quality, Ministry of Agriculture of the Netherlands
SESSION 4: RESPONSIBLE AND PRUDENT USE OF VETERINARY ANTIMICROBIALS: PRACTICAL TOOLS AND EXPERIENCES
_ The OIE strategy on antimicrobial resistance and the prudent use of antimicrobials, Elisabeth Erlacher-Vindel/David Sherman, World Organisation for Animal Health, OIE
_ World Veterinary Association’s experience and supportive tools to promote prudent use of antimicrobials worldwide, Zeev Noga, World Veterinary Association
_ Country level implementation: FAO experience including aquaculture, Melba Reantaso, Food and Agriculture Organization of the United Nations
SESSION 5: SURVEILLANCE AND MONITORING TOWARDS EFFECTIVE MANAGEMENT OF ANTIMICROBIAL RESISTANCE
_ OIE Database on antimicrobial agents intended for use in animals: third phase results, Delfy Góchez, World Organisation for Animal Health, OIE
_ Global antimicrobial resistance surveillance initiatives: updates from the WHO GLASS and FAO ATLASS, Carmem Pessoa, World Health Organization/Beatrice Mouillé, Food and Agriculture Organization of the United Nations
_ Integrated surveillance of antimicrobial resistance in the food chain: challenges, Sarah Cahill, Codex Alimentarius Commission
_ Experience on integrated surveillance at country level: AGISAR country pilot projects and the tricycle project (Part1/ Part2) Awa Aidara-Kane, World Health Organization
SESSION 6: INDUSTRY PANEL: DRIVING PRIVATE SECTOR ENGAGEMENT IN THE GLOBAL RESPONSE TO ANTIMICROBIAL RESISTANCE
_ Round table
SESSION 7: PROMOTING ACCESS TO HIGH QUALITY VETERINARY ANTIMICROBIALS
_ Promoting access to high quality veterinary antimicrobials, Norbert Mencke, HealthforAnimals
_ Customs experience, challenges and findings, Satoko Kagawa, World Customs Organization
_ Antiparasitical resistance, a growing challenge, Patrick Vudriko, Uganda Makerere University
_ Country experiences:
-Thailand (Part1 / Part 2): Sasi Jaroenpoj, Animal Feed and Veterinary Products Control Division Department of Livestock Development
–Morocco: Khadija Id Sidi Yahia, National Office of Food Safety
–Argentina: Federico Alberto Luna, National Agrifood Health and Quality Service
SESSION 8: RESEARCH AND FUTURE DEVELOPMENTS IN COMBATTING ANTIMICROBIAL RESISTANCE
_ The road towards the research and development of alternatives to antibiotics, Cyril Gay, Agricultural Research Service, United States Department of Agriculture
_ Prioritisation of diseases for which vaccines could reduce antimicrobial use in animals, Gérard Moulin, French agency for veterinary medicinal products
_ The use of economics for selecting interventions and policies, Jonathan Rushton, University of Liverpool
_ The economic benefits and costs of antimicrobial use in food animal production: what lessons can be drawn? Michael Ryan, Organisation for Economic Co-operation and Development
SESSION 10: RECOMMENDATIONS AND CLOSING
1/ Countries and regions exempted from the entry visa to Morocco:
|ANDORRA||HONG KONG (for a trip limited to 30 days)||PHILIPPINES|
|ARGENTINA||HUNGARY (for a trip limited to 30 days)||POLAND|
|BULGARIA||KOREA (REP. OF)||SAN MARINO|
|CHINA (PEOPLE’S REP. OF)||LIECHTENSTEIN||SINGAPORE|
|CONGO (REP. OF)||LITUANIA||SLOVAKIA|
|FINLAND||NETHERLANDS (THE)||UNITED ARAB EMIRATES|
|FRANCE||NEW ZEALAND||UNITED KINGDOM|
|GABON||NIGER||UNITED STATES OF AMERICA|
2/ Countries and regions requiring a visa to travel to Morocco:
a) Countries and regions with a diplomatic representation of Morocco:
|CENTRAL AFRICAN REPUBLIC||KENYA||SOUTH AFRICA|
|CONGO (DEM. REP. OF THE)||KOREA (DEM. PEOPLE’S REP. OF)||SUDAN|
* Visa application must be done at the Moroccan embassy in Tunis.
Participants from the aforementioned countries/regions must apply for visa in the relevant Moroccan diplomatic representation in their countries. For more information, please consult the following link (section Les Représentations marocaines à l’étranger) : #.
The visa type to apply for is: Participation aux colloques et conférences. In order for the OIE to support the visa application, participants should send as soon as possible to email@example.com the scanned copy of their passport clearly indicating whether it is an ordinary, diplomatic or service passport. Please note that the decision on visa issuance is at the discretion of the Moroccan authorities.
b) Countries and regions without a diplomatic representation of Morocco:
|AFGHANISTAN||FORMER YUG. REP. OF MACEDONIA||NICARAGUA|
|ARMENIA||GAMBIA||PAPUA NEW GUINEA|
|BENIN||ISRAEL||SOUTH SUDAN (REP. OF)|
|BOSNIA AND HERZEGOVINA||KYRGYZSTAN||SWAZILAND|
|CAMBODIA||MALDIVES||TRINIDAD AND TOBAGO|
|COMOROS||MICRONESIA (FEDERATED STATES OF)||UGANDA|
Participants from the aforementioned countries/regions must compulsorily send as soon as possible the scanned copy of their passport to the OIE (firstname.lastname@example.org) clearly indicating whether it is an ordinary, diplomatic or service passport. The OIE will take care of the visa procedure and, if the visa application is accepted, we will inform participants accordingly and they will be able to get their visa on arrival at the airport of entry in Morocco. Please note that the cost of the visa is 300 MAD (about 30 EUR/USD and participants will be asked to pay it upon arrival at the airport in order to be able to recover it.
3/ Arrival in Morocco:
Upon arrival at the airport of entry in Morocco, you will need to provide the Border Services Officer with the duly completed document Fiche d’embarquement/débarquement. Some airlines distribute this document during the flight, but if not, you will find it when you arrive in the border control area. Please do not forget to fill out this document before passing the Border Services checkpoint or you will have to queue again.
The conference venue is surrounded by a large variety of accommodation options to suite all budgets. Among them, you will find hereafter our selection. We strongly recommend you to contact the hotels as soon as possible in order to get the best rates available.
To book a room at the Palmeraie Palace, which is also the conference venue, please contact Ms Jihane Haraoui (email@example.com) and indicate that you are a participant to the conference.
Palmeraie Palace (5*)
Circuit de la Palmeraie
BP 1488, 40000 Marrakesh, Morocco
|Room||Price in MAD|
|Traditional (single)||From 1 500 MAD+ taxes and/or tips|
|Traditional (double)||From 1 650 MAD+ taxes and/or tips|
A credit card may be required to guarantee the booking.
|Hotel||Average prices in MAD per room per night*||Booking information|
|Hotel Riad Ennakhil & SPA (5*)||
Single: from 653 MAD
Double: from 729 MAD
|Résidence Pavillon du Golf (5*)||
Single/Double: from 947 MAD
|Hôtel du Golf (4*)||
Single : 1 350 MAD
Double : 1 500 MAD
To book at the Hôtel du Golf, please contact Ms Jihane Haraoui (firstname.lastname@example.org) and indicate that you are a participant to the conference
|Résidence Palmeraie Village (4*)||
Single/Double: from 816 MAD
|Ibis Marrakech Palmeraie (3*)||
Single: 435 MAD
Double: 500 MAD
*Kindly note that prices are for a standard room without taxes included, and may vary depending on the period of the booking and the selected dates of stay.
– The easiest way to go from Marrakesh airport to the hotel Palmeraie Palace Marrakesh (conference venue) is by cab and it takes about 30 minutes.
The average cost to take a cab from the airport to the Palmeraie Marrakesh is approximatively 100-150 MAD (please make sure you negotiate the price before getting in the cab). The vehicles are plentiful and are available outside of the arrivals terminal.
– From Casablanca airport to the hotel Palmeraie Palace Marrakesh (conference venue), we advise you to book a cab in advance as it is a 3 hours drive.
To book your taxi ride in advance, please consult the following taxi companies’ websites (non-exhaustive list):
||Antimicrobial resistance in animal and public health, Scientific and Technical Review, Vol. 31 (1)
The focus of this Review is to address the various factors that must be taken into account when trying to understand the antimicrobial resistance problem, with a particular focus on the use of antimicrobials in animals.
||OIE Standards, Guidelines and Resolution on antimicrobial resistance and the use of antimicrobial agents This special publication has been prepared to support the Global Action Plan on Antimicrobial Resistance (GAP-AMR) that WHO is developing in collaboration with FAO and OIE.|
||Responsible and Prudent Use of Antimicrobial Agents for Animals
International Solidarity to fight against Antimicrobial Resistance This booklet in English gives a summary of the presentations made at this important global conference and includes the recommendations adopted by the Scientific Committee of the conference and all its participants.
OPEN ACCESS FREE DOCUMENTS :
|First and second OIE Annual reports on the use of antimicrobial agents in animals|
|The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials
Animal health and welfare depend on the availability, effectiveness, and appropriate use of quality antimicrobial products. The OIE has published its Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials to tackle the antimicrobial resistance threat.
|Antimicrobial resistance factsheet|
Antimicrobial Resistance (AMR)
Kindly return the completed form as an attachment before Monday, 22 October, 2018. No access will be permittedv without prior accreditation
SOCIAL MEDIA ACTIVITY
World Organisation for Animal Health (OIE)
12 rue de Prony, 75017 Paris
Tel: 33 (0) 1 44 15 18 65
Fax: 33 (0) 1 42 67 09 87
Under the high patronage of His Majesty, King Mohamed VI
With the support of
Organised with the financial support of the Kingdom of Morocco, the People’s Republic of China, the European Union, France, Germany, Italy, Japan, the Netherlands, Norad, the Pew Charitable Trusts, the United Kingdom Fleming Fund and the Unites States of America. The OIE would also like to thank the Kingdom of Morocco for its significant support in organising this conference.
This conference is also organised with the financial support of Zoetis